Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2024-06-17 00:00:00 ET · period of report 2024-06-14 · accession 0001562180-24-005118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-17 | 2024-06-14 | SNDX | Goldan Keith A. | CFO | P - Purchase | $20.03 | +1,250 | 52.6K | +2% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | P | A | 1,250 | $20.03 | 52,623 | D | — | — |